Edison Scientific is a biotechnology company developing an artificial intelligence platform designed to accelerate scientific research and development, particularly in the discovery and early development of new medicines. Founded in 2025, the company secured a $70 million seed funding round to support its work.
The company's primary product is Kosmos, an AI system built to function as an autonomous scientist. Kosmos is engineered to independently analyse scientific literature, write and execute analysis code, formulate hypotheses, and generate comprehensive, cited research reports. According to the company, a single run of the system processes approximately 1,500 academic papers and executes around 42,000 lines of code, a volume of work it equates to roughly six months of effort by a PhD or postdoctoral researcher.
Edison Scientific's technical focus spans autonomous literature analysis, code generation and execution, and hypothesis generation within an AI-for-science framework. The platform targets applications in both the biopharmaceutical industry and academic research.
